Use of recombinant allergens and antigens in clinical diagnosis (Q12379): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Created claim: summary (P836): The subject of the project is industrial research and experimental development focused on the field of in vitro diagnostics, namely the use of recombinant allergens and antigens in the form of prototypes of BAT tests and ELISA kits for qualitative diagnostics and monitoring of therapy of allergological reactions of patients and selected bacterial infections. The resulting high-tech products will match the parameters of the world’s top, or excee...)
(‎Changed label, description and/or aliases in 2 languages: Changing unique label-description pair)
description / endescription / en
Project in Czech Republic financed by DG Regio
Project Q12379 in Czech Republic
description / csdescription / cs
Projekt v České republice financovaný DG Regio
Projekt Q12379 v Czechia

Revision as of 15:56, 28 October 2020

Project Q12379 in Czech Republic
Language Label Description Also known as
English
Use of recombinant allergens and antigens in clinical diagnosis
Project Q12379 in Czech Republic

    Statements

    0 references
    15,323,532.49 Czech koruna
    0 references
    612,941.30 Euro
    10 January 2020
    0 references
    24,835,547.0 Czech koruna
    0 references
    993,421.88 Euro
    10 January 2020
    0 references
    61.7 percent
    0 references
    30 June 2022
    0 references
    EXBIO Praha, a.s.
    0 references
    0 references

    49°59'0.49"N, 14°30'9.11"E
    0 references
    25250
    0 references
    Předmětem projektu je průmyslový výzkum a experimentální vývoj zaměřený na oblast diagnostik in vitro, konkrétně na využití rekombinantních alergenů a antigenů v podobě prototypů BAT testů a ELISA souprav pro kvalitativní diagnostiku a monitoring terapie alergologických reakcí pacientů a vybraných bakteriálních infekcí. Výsledné high-tech produkty se vyrovnají parametrům světové špičky, resp. překračují technické parametry známých řešení a budou uvedeny na evropský a světový trh. a. (Czech)
    0 references
    The subject of the project is industrial research and experimental development focused on the field of in vitro diagnostics, namely the use of recombinant allergens and antigens in the form of prototypes of BAT tests and ELISA kits for qualitative diagnostics and monitoring of therapy of allergological reactions of patients and selected bacterial infections. The resulting high-tech products will match the parameters of the world’s top, or exceed the technical parameters of known solutions and will be introduced to the European and world market. a. (English)
    22 October 2020
    0 references

    Identifiers

    CZ.01.1.02/0.0/0.0/17_176/0015521
    0 references